Sales rise 8.38% to Rs 94.95 crore
Net profit of Sterling Biotech reported to Rs 36.97 crore in the quarter ended December 2018 as against net loss of Rs 168.02 crore during the previous quarter ended December 2017. Sales rose 8.38% to Rs 94.95 crore in the quarter ended December 2018 as against Rs 87.61 crore during the previous quarter ended December 2017. ParticularsQuarter EndedDec. 2018Dec. 2017% Var.Sales94.9587.61 8 OPM %11.944.43 -PBDT114.35-106.58 LP PBT52.88-168.02 LP NP36.97-168.02 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
